The quadrivalent flu vaccine will still be available, as it was approved for the 2023/2024 season and is still being used in some countries.

Generally speaking, Influenza vaccines are safe for most but specifically encouraged for those over 65 years of age, those working with young, elderly or infirm patients and those with chronic medical conditions.

From the information available, we expect that most medical aids will cover the 3- or 4-strain vaccine. For those needing a cash price, the trivalent option will be offered at R99 and the quadrivalent at R149.

Online Resources:

https://www.clinicaltrialsarena.com/analyst-comment/who-trivalent-recommendations-expected-to-reshape-global-influenza-vaccine-market/

https://www.who.int/news/item/23-02-2024-recommendations-announced-for-influenza-vaccine-composition-for-the-2024-2025-northern-hemisphere-influenza-season